GENinCode has announced the launch of its Risk of Ovarian Cancer Algorithm (ROCA) surveillance test through the company’s collaboration with the North Central London (NCL) Cancer Alliance and University College London Hospitals NHS Foundation Trust (UCLH). UCLH becomes the first hospital trust in the UK to provide the test. The ROCA test calculates a woman’s individual risk of ovarian cancer based on several clinical factors including the presence of cancer-causing gene variants in the BRCA1 or ....
